Full Story: "Heart attack patients treated with anti-thrombosis drugs instead of the blood-thinner heparin are less likely to die or have another heart attack, researchers told a meeting of cardiologists on Tuesday.'This is a better blood-thinning strategy for patients who have a heart attack,' said Harvard Medical School professor Dr. Elliott Antman, lead investigator of the trial comparing the drug Lovenox to heparin."